Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.45 - $0.86 $38,113 - $72,838
-84,696 Reduced 4.16%
1,950,478 $1.02 Million
Q3 2022

Nov 14, 2022

SELL
$0.46 - $0.63 $73,720 - $100,965
-160,263 Reduced 7.3%
2,035,174 $916,000
Q2 2022

Aug 12, 2022

SELL
$0.47 - $0.87 $50,603 - $93,669
-107,666 Reduced 4.67%
2,195,437 $1.27 Million
Q1 2022

May 13, 2022

BUY
$0.75 - $1.77 $185,674 - $438,191
247,566 Added 12.04%
2,303,103 $1.82 Million
Q4 2021

Feb 11, 2022

BUY
$1.56 - $2.93 $87,984 - $165,252
56,400 Added 2.82%
2,055,537 $3.33 Million
Q3 2021

Nov 12, 2021

BUY
$2.91 - $4.83 $353,274 - $586,362
121,400 Added 6.47%
1,999,137 $6 Million
Q2 2021

Aug 13, 2021

BUY
$4.17 - $5.74 $117,594 - $161,868
28,200 Added 1.52%
1,877,737 $8.77 Million
Q1 2021

May 13, 2021

SELL
$5.28 - $9.64 $190,692 - $348,158
-36,116 Reduced 1.92%
1,849,537 $9.77 Million
Q4 2020

Feb 10, 2021

BUY
$5.75 - $7.13 $1.07 Million - $1.33 Million
186,616 Added 10.98%
1,885,653 $12.3 Million
Q3 2020

Nov 13, 2020

BUY
$4.9 - $7.12 $1.18 Million - $1.71 Million
239,900 Added 16.44%
1,699,037 $10.4 Million
Q2 2020

Aug 13, 2020

BUY
$6.43 - $9.86 $2.4 Million - $3.67 Million
372,700 Added 34.3%
1,459,137 $10.6 Million
Q1 2020

May 14, 2020

SELL
$6.36 - $10.05 $1.31 Million - $2.07 Million
-206,100 Reduced 15.95%
1,086,437 $7.55 Million
Q4 2019

Feb 13, 2020

SELL
$8.49 - $12.81 $7.81 Million - $11.8 Million
-920,400 Reduced 41.59%
1,292,537 $11.4 Million
Q3 2019

Nov 13, 2019

BUY
$5.58 - $14.47 $12 Million - $31.1 Million
2,150,837 Added 3463.51%
2,212,937 $24.8 Million
Q2 2019

Aug 12, 2019

BUY
$5.22 - $9.08 $324,162 - $563,868
62,100 New
62,100 $376,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.